Healthcare reform and a desire for

Hindered by redundancies in the approval process, problems securing suitable data for clinical trials, and disparities in the drug classification system between China and other countries, foreign companies have rarely found it easy to navigate China’s lengthy regulatory framework for approving pharmaceuticals and medical devices.